Guru Ownership Trend
Guru Analysis for Palvella Therapeutics, Inc. (PVLA)
Palvella Therapeutics, Inc. (PVLA), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $15.69 M.
Top institutional holders include Steven Cohen and Chuck Royce.
Institutional sentiment is currently Bullish. This is evidenced by a $972,269.89 net inflow during the quarter.
Recent activity highlights Steven Cohen who increased their stake by 14.1%. Conversely, Renaissance Technologies (RenTech) reduced exposure by 20.2%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Palvella Therapeutics, Inc. (PVLA)
Major holders include Steven Cohen ($10.99 M), Chuck Royce ($3.93 M), Renaissance Technologies (RenTech) ($2.24 M). According to the latest reported data, 3 tracked investment managers collectively hold approximately 137,637 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $972,269.89, with 2 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited PVLA. The total reported sell value was $568,404.13.
Yes, 0 managers opened new positions in PVLA, and 2 increased their existing holdings. The total reported buy value was $1.54 M.